187 related articles for article (PubMed ID: 15203883)
1. Effect of fidarestat and alpha-lipoic acid on diabetes-induced epineurial arteriole vascular dysfunction.
Yorek MA; Coppey LJ; Gellett JS; Davidson EP; Lund DD
Exp Diabesity Res; 2004; 5(2):123-35. PubMed ID: 15203883
[TBL] [Abstract][Full Text] [Related]
2. Effect of antioxidant treatment of streptozotocin-induced diabetic rats on endoneurial blood flow, motor nerve conduction velocity, and vascular reactivity of epineurial arterioles of the sciatic nerve.
Coppey LJ; Gellett JS; Davidson EP; Dunlap JA; Lund DD; Yorek MA
Diabetes; 2001 Aug; 50(8):1927-37. PubMed ID: 11473057
[TBL] [Abstract][Full Text] [Related]
3. Effect of M40403 treatment of diabetic rats on endoneurial blood flow, motor nerve conduction velocity and vascular function of epineurial arterioles of the sciatic nerve.
Coppey LJ; Gellett JS; Davidson EP; Dunlap JA; Lund DD; Salvemini D; Yorek MA
Br J Pharmacol; 2001 Sep; 134(1):21-9. PubMed ID: 11522593
[TBL] [Abstract][Full Text] [Related]
4. Effect of treating streptozotocin-induced diabetic rats with sorbinil, myo-inositol or aminoguanidine on endoneurial blood flow, motor nerve conduction velocity and vascular function of epineurial arterioles of the sciatic nerve.
Coppey LJ; Gellett JS; Davidson EP; Dunlap JA; Yorek MA
Int J Exp Diabetes Res; 2002; 3(1):21-36. PubMed ID: 11900277
[TBL] [Abstract][Full Text] [Related]
5. Aldose reductase inhibition counteracts oxidative-nitrosative stress and poly(ADP-ribose) polymerase activation in tissue sites for diabetes complications.
Obrosova IG; Pacher P; Szabó C; Zsengeller Z; Hirooka H; Stevens MJ; Yorek MA
Diabetes; 2005 Jan; 54(1):234-42. PubMed ID: 15616034
[TBL] [Abstract][Full Text] [Related]
6. Slowing of motor nerve conduction velocity in streptozotocin-induced diabetic rats is preceded by impaired vasodilation in arterioles that overlie the sciatic nerve.
Coppey LJ; Davidson EP; Dunlap JA; Lund DD; Yorek MA
Int J Exp Diabetes Res; 2000; 1(2):131-43. PubMed ID: 11469397
[TBL] [Abstract][Full Text] [Related]
7. Changes in endoneurial blood flow, motor nerve conduction velocity and vascular relaxation of epineurial arterioles of the sciatic nerve in ZDF-obese diabetic rats.
Coppey LJ; Gellett JS; Davidson EP; Dunlap JA; Yorek MA
Diabetes Metab Res Rev; 2002; 18(1):49-56. PubMed ID: 11921418
[TBL] [Abstract][Full Text] [Related]
8. Effect of combination therapy consisting of enalapril, α-lipoic acid, and menhaden oil on diabetic neuropathy in a high fat/low dose streptozotocin treated rat.
Davidson EP; Holmes A; Coppey LJ; Yorek MA
Eur J Pharmacol; 2015 Oct; 765():258-67. PubMed ID: 26291662
[TBL] [Abstract][Full Text] [Related]
9. Preventing superoxide formation in epineurial arterioles of the sciatic nerve from diabetic rats restores endothelium-dependent vasodilation.
Coppey LJ; Gellett JS; Davidson EP; Yorek MA
Free Radic Res; 2003 Jan; 37(1):33-40. PubMed ID: 12653215
[TBL] [Abstract][Full Text] [Related]
10. Effect of the aldose reductase inhibitor fidarestat on experimental diabetic neuropathy in the rat.
Kuzumoto Y; Kusunoki S; Kato N; Kihara M; Low PA
Diabetologia; 2006 Dec; 49(12):3085-93. PubMed ID: 17063327
[TBL] [Abstract][Full Text] [Related]
11. Alpha-lipoic acid: effect on glucose uptake, sorbitol pathway, and energy metabolism in experimental diabetic neuropathy.
Kishi Y; Schmelzer JD; Yao JK; Zollman PJ; Nickander KK; Tritschler HJ; Low PA
Diabetes; 1999 Oct; 48(10):2045-51. PubMed ID: 10512372
[TBL] [Abstract][Full Text] [Related]
12. Glutathione and alpha-lipoate in diabetic rats: nerve function, blood flow and oxidative state.
van Dam PS; van Asbeck BS; Van Oirschot JF; Biessels GJ; Hamers FP; Marx JJ
Eur J Clin Invest; 2001 May; 31(5):417-24. PubMed ID: 11380593
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the effects of inhibitors of aldose reductase and sorbitol dehydrogenase on neurovascular function, nerve conduction and tissue polyol pathway metabolites in streptozotocin-diabetic rats.
Cameron NE; Cotter MA; Basso M; Hohman TC
Diabetologia; 1997 Mar; 40(3):271-81. PubMed ID: 9084964
[TBL] [Abstract][Full Text] [Related]
14. Acetylcholine-induced arteriolar dilation is reduced in streptozotocin-induced diabetic rats with motor nerve dysfunction.
Terata K; Coppey LJ; Davidson EP; Dunlap JA; Gutterman DD; Yorek MA
Br J Pharmacol; 1999 Oct; 128(3):837-43. PubMed ID: 10516670
[TBL] [Abstract][Full Text] [Related]
15. Aldose reductase inhibition, nerve perfusion, oxygenation and function in streptozotocin-diabetic rats: dose-response considerations and independence from a myo-inositol mechanism.
Cameron NE; Cotter MA; Dines KC; Maxfield EK; Carey F; Mirrlees DJ
Diabetologia; 1994 Jul; 37(7):651-63. PubMed ID: 7958535
[TBL] [Abstract][Full Text] [Related]
16. Diabetes-induced changes in lens antioxidant status, glucose utilization and energy metabolism: effect of DL-alpha-lipoic acid.
Obrosova I; Cao X; Greene DA; Stevens MJ
Diabetologia; 1998 Dec; 41(12):1442-50. PubMed ID: 9867211
[TBL] [Abstract][Full Text] [Related]
17. Effect of a potent new aldose reductase inhibitor, (5-(3-thienyltetrazol-1-yl)acetic acid (TAT), on diabetic neuropathy in rats.
Hotta N; Kakuta H; Fukasawa H; Koh N; Sakakibara F; Nakamura J; Hamada Y; Wakao T; Hara T; Mori K
Diabetes Res Clin Pract; 1995 Feb; 27(2):107-17. PubMed ID: 7607048
[TBL] [Abstract][Full Text] [Related]
18. Effect of treatment of diabetic rats with dehydroepiandrosterone on vascular and neural function.
Yorek MA; Coppey LJ; Gellett JS; Davidson EP; Bing X; Lund DD; Dillon JS
Am J Physiol Endocrinol Metab; 2002 Nov; 283(5):E1067-75. PubMed ID: 12376336
[TBL] [Abstract][Full Text] [Related]
19. Treatment of streptozotocin-induced diabetic rats with AVE7688, a vasopeptidase inhibitor: effect on vascular and neural disease.
Davidson EP; Kleinschmidt TL; Oltman CL; Lund DD; Yorek MA
Diabetes; 2007 Feb; 56(2):355-62. PubMed ID: 17259379
[TBL] [Abstract][Full Text] [Related]
20. Effects of 15-month aldose reductase inhibition with fidarestat on the experimental diabetic neuropathy in rats.
Kato N; Mizuno K; Makino M; Suzuki T; Yagihashi S
Diabetes Res Clin Pract; 2000 Oct; 50(2):77-85. PubMed ID: 10960717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
